StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
1735.TW$25.15-0.59%
Fair $25.15+0.0%

1735.TW

Evermore Chemical Industry Co., Ltd.

Basic Materials / ChemicalsTaiwan

$25.15

-0.15 (-0.59%)

Fairly Valued+0.0%Fair Value $25.15Fund rank 35/100 · Data gapFallback financials|
SA 46/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $172.4M · quality 72.0/100

Data gap 35/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 68/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

46/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · 1735.TWLocal privado en este navegador · Evermore Chemical Industry Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.5B

P/E

32.2x

↑

EV/EBITDA

13.2x

↑

ROE

5.0%

↑

Gross Margin

18.1%

↓

Debt/Equity

0.64

↑
52-Week Range$25
$14$34

TradingView lightweight chart

1735.TW price, volumen y niveles de valoración

Último $25.15Periodo -2.6%
Fair value: $25.15

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-8.0%

FCF CAGR

-11.5%

FCF margin

7.5%

FCF / Net income

2.22x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.30B · net income $77.6M · FCF $172.4M

2022-FY → 2025-FY

Gross margin

18.1%+5.1% pts

Operating margin

2.2%+2.0% pts

Net margin

3.4%+2.2% pts

FCF margin

7.5%-0.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$2.30B$2.30B$2.65B$2.37B$2.96B
Net Income$77.6M$77.6M$96.4M$75.2M$35.2M
EBITDA$234.8M$234.8M$264.0M$227.4M$175.8M
EPS——0.970.750.35
Gross Margin18.1%18.1%17.7%18.6%13.1%
Operating Margin2.2%2.2%2.8%2.9%0.3%
Net Margin3.4%3.4%3.6%3.2%1.2%
Balance Sheet
Debt/Equity0.640.640.770.901.01
Current Ratio1.261.26———
Cash Flow
Free Cash Flow$172.4M$172.4M$142.4M$371.4M$249.0M
Returns
ROE5.0%5.0%6.1%5.0%2.4%
Valuation
P/E32.2432.2421.0322.8043.43
EV/EBITDA13.2113.2111.0211.7615.99
P/B1.611.611.291.141.01
Growth & Yield
Revenue Growth-12.9%-12.9%11.8%-19.9%—
EPS Growth——29.3%114.3%—
Dividend Yield3.2%3.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +56.5%

Total return

+56.5%

Start / end P/E

n/dx → n/dx

EPS bridge

0.97 → n/d

Residual

+53.4%

EPS growthn/d
Multiple reratingn/d
Dividend+3.2%
Residual / FX / buybacks / cross-term+53.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.